ACE2 and COVID-19: Several studies have focused on the specific viral mechanisms of infection pointing to a shared entry pathway with previous coronaviruses, suggesting the involvement of surface receptor for S1 of the angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine-2 (TMPRSS2) receptor in COVID-19 [2].